APO-WARFARIN
As listed in the register: APO-WARFARIN
2 mg · tablet
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Warfarin Sodium
- Used in
- Blood, clotting and anaemia
- Made by
- Apotex Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Warfarin Sodium). It describes the substance, not this exact product.
12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S.
Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K-dependent clotting factors.
Warfarin is stereoselectively metabolized by hepatic cytochrome P-450 (CYP450) microsomal enzymes to inactive hydroxylated metabolites (predominant route) and by reductases to reduced metabolites (warfarin alcohols) with minimal anticoagulant activity.
Very little warfarin is excreted unchanged in urine.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-31
Safety of the active substance
From the US prescribing label for the same active substance (Warfarin Sodium). It describes the substance, not this exact product.
WARNING: BLEEDING RISK Warfarin sodium can cause major or fatal bleeding [see Warnings and Precautions (5.1) ].
- Warfarin sodium is contraindicated in: Pregnancy Warfarin sodium is contraindicated in women who are pregnant except in pregnant women with mechanical heart valves, who are at high risk of thromboembolism [see Warnings and Precautions (5.7) and Use in Specific Populations (8.1 )].
- Warfarin sodium can cause fetal harm when administered to a pregnant woman.
- Warfarin sodium exposure during pregnancy causes a recognized pattern of major congenital malformations (warfarin embryopathy and fetotoxicity), fatal fetal hemorrhage, and an increased risk of spontaneous abortion and fetal mortality.
- If warfarin sodium is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus [see Use in Specific Populations (8.1) ].
Most common adverse reactions to warfarin sodium are fatal and nonfatal hemorrhage from any tissue or organ.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States14 matching products
SpainNo exact match for this strength and form
Details
| Made by | Apotex Inc |
|---|---|
| Active substance | Warfarin Sodium |
| Used in | Blood, clotting and anaemia |
| Strength | 2 mg |
| Form | tablet |
| Classification | B01AA03 · Blood, clotting and anaemia |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02242925 |
| DPD drug code | 66763 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
7 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.